Therapeutic drug monitoring (TDM) of adalimumab clinical trials

Effect of Proactive Therapeutic Drug Monitoring on Maintenance of Sustained Disease Control in Adults With Rheumatoid Arthritis on a Subcutaneous TNF Inhibitor: The Rheumatoid Arthritis Therapeutic DRUg Monitoring Trial (RA-DRUM)

This study looks at how best to manage rheumatoid arthritis for people taking a common treatment called adalimumab. Researchers will check drug levels in the blood to see if this helps keep the condition under control better than usual care and prevents flare-ups.